Working to find actionable solutions to the nation's key challenges.

Bringing Cellular Therapy from the Bench to the Bedside: New BPC Recommendations

Tuesday, November 24, 2015

Washington, D.C. – To keep the United States at the forefront of medical innovation, federal policies need to incentivize new technologies for the benefits of patients. One of the most promising areas for groundbreaking treatments in the fields of cardiology, neurology, ophthalmology, and orthopedics is regenerative cellular therapies. On Wednesday, December 2, the Bipartisan Policy Center will release recommendations on the ways the U.S. can accelerate the availability of safe and effective cellular therapies to Americans and improve our nation’s competitiveness. An engaging discussion will follow with leading scientific experts in the field.

Members of the press wishing to attend, please RSVP to Joann Donnellan [email protected].

Join the discussion on Twitter: @BPC_Bipartisan #BPClive


WHO:

Bill Frist, MD
Co-Chair, FDA: Advancing Medical Innovation, BPC
Former Senate Majority Leader
@bfrist

Bart Gordon
Co-Chair, FDA: Advancing Medical Innovation, BPC
Former Representative from Tennessee

Senator Mark Kirk (R-IL)
Member, Senate Health, Education, Labor, and Pensions Committee
@SenatorKirk

Anthony Atala, MD
Director of the Wake Forest Institute for Regenerative Medicine
W.H. Boyce Professor and Chair of the Department of Urology at Wake Forest University

Joanne Kurtzberg, MD
Professor of Pediatrics and Professor of Pathology, Duke University of Medicine
Chief Scientific Officer, Robertson Clinical and Translational Cell Therapy Program

Randy Mills, PhD*
President and CEO, California Institute for Regenerative Medicine

Evan Snyder, MD, PhD*
Professor, Sanford Burnham Medical Research Institute
Director, Stem Cell and Regenerative Biology Program, University of California – San Diego

Andre Terzic, MD, PhD
Director, Mayo Clinic Center for Regenerative Medicine

Andrew von Eschenbach, MD
President, Samaritan Health Initiatives
Former Commissioner, Food and Drug Administration

Janet Marchibroda
Director of Health Innovation, BPC

WHAT:

Advancing Regenerative Cellular Therapies for Americans

WHEN:

Wednesday, December 2, 2015
9:00 AM – 10:30 AM ET

WHERE:

Hart Senate Office Building
Room 216
Washington, DC 20002

KEYWORDS: 21ST CENTURY CURES, BILL FRIST, MARK KIRK